OpenAlex
PricingAboutJobs
Log inGet started
Work

Amelioration of diabetes by imatinib mesylate (Gleevec®): role of ‐cell NF‐KB activation and anti‐apoptotic preconditioning

HTML

Year: 2006
Type: article
Source: The FASEB Journal
DOI: 10.1096/fj.06-6910com
Authors: Robert Hägerkvist, Stellan Sandler, Dariush Mokhtari, Nils Welsh
Institution: Uppsala University
Language: English

Topic: Pancreatic function and diabetes
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: imatinib mesylate, type 2 diabetes, beta-cell survival, beta-cell apoptosis, NF-κB activation, c-Abl, ischemic preconditioning, nitric oxide, reactive oxygen species, mitochondrial depolarization, streptozotocin, tyrosine kinase inhibitors, beta-cell dysfunction
SDG: Good health and well-being

Open Access status: closed

Funder: Vetenskapsrådet
OpenAlex ID: W1993124906
FWCI: 2.986
Cites: 37
Cited by: 137
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security